BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19656356)

  • 1. Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.
    Miyazaki Y; DeFronzo RA
    Cardiovasc Diabetol; 2009 Aug; 8():44. PubMed ID: 19656356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus.
    Miyazaki Y; Glass L; Triplitt C; Wajcberg E; Mandarino LJ; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1135-43. PubMed ID: 12424102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
    Bishay RH; Tonks KT; George J; Samocha-Bonet D; Meyerowitz-Katz G; Chisholm DJ; James DE; Greenfield JR
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1131-e1139. PubMed ID: 33347566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance training enhances insulin suppression of endogenous glucose production in elderly women.
    Honka MJ; Bucci M; Andersson J; Huovinen V; Guzzardi MA; Sandboge S; Savisto N; Salonen MK; Badeau RM; Parkkola R; Kullberg J; Iozzo P; Eriksson JG; Nuutila P
    J Appl Physiol (1985); 2016 Mar; 120(6):633-9. PubMed ID: 26744506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
    Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of visceral fat accumulation in type 2 diabetes.
    Gastaldelli A; Miyazaki Y; Pettiti M; Matsuda M; Mahankali S; Santini E; DeFronzo RA; Ferrannini E
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5098-103. PubMed ID: 12414878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat.
    Goodpaster BH; Thaete FL; Simoneau JA; Kelley DE
    Diabetes; 1997 Oct; 46(10):1579-85. PubMed ID: 9313753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study.
    Neeland IJ; Singh S; McGuire DK; Vega GL; Roddy T; Reilly DF; Castro-Perez J; Kozlitina J; Scherer PE
    Diabetologia; 2018 Dec; 61(12):2570-2579. PubMed ID: 30159588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals.
    Koska J; Stefan N; Permana PA; Weyer C; Sonoda M; Bogardus C; Smith SR; Joanisse DR; Funahashi T; Krakoff J; Bunt JC
    Am J Clin Nutr; 2008 Feb; 87(2):295-302. PubMed ID: 18258617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study.
    Brochu M; Mathieu ME; Karelis AD; Doucet E; Lavoie ME; Garrel D; Rabasa-Lhoret R
    Obesity (Silver Spring); 2008 May; 16(5):1085-93. PubMed ID: 18356851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.
    Bajaj M; Suraamornkul S; Hardies LJ; Pratipanawatr T; DeFronzo RA
    Int J Obes Relat Metab Disord; 2004 Jun; 28(6):783-9. PubMed ID: 15024400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies.
    Hwang JH; Stein DT; Barzilai N; Cui MH; Tonelli J; Kishore P; Hawkins M
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1663-9. PubMed ID: 17911339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes.
    Huang H; Zheng X; Wen X; Zhong J; Zhou Y; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1144834. PubMed ID: 36909323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the serum concentrations of C-reactive protein and parameters of adiposity and insulin resistance in patients with type 2 diabetes mellitus.
    Iwasaki T; Nakajima A; Yoneda M; Terauchi Y
    Endocr J; 2006 Jun; 53(3):345-56. PubMed ID: 16714840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral fat and adiponectin: associations with insulin resistance are tissue-specific in women.
    Coker RH; Williams RH; Yeo SE; Kortebein PM; Bodenner DL; Kern PA; Evans WJ
    Metab Syndr Relat Disord; 2009 Feb; 7(1):61-7. PubMed ID: 19032037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.